An understanding the genetic basis of congenital heart disease

Indian Journal of Human Genetics

Volumn 11, Issue 1, 2005, Pages 14-23

  Ramegowda, Smitha ^a   Ramachandra, Nallur B ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Chromosome; Congenital heart disease; GATA 4; NKX 2.5; Syndrome; Transcription factors

Indexed keywords

ELASTIN; FIBRILLIN; JAGGED1; PROTEIN; PROTEIN TBX5; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

AORTA COARCTATION; AORTA STENOSIS; CARDIOVASCULAR RISK; CAT EYE SYNDROME; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CONGENITAL HEART DISEASE; DEXTROCARDIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOWN SYNDROME; EBSTEIN ANOMALY; EDWARDS SYNDROME; ELLIS VAN CREVELD SYNDROME; FALLOT TETRALOGY; FRAGILE X SYNDROME; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART INJURY; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SINGLE VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INCIDENCE; KABUKI MAKEUP SYNDROME; LUNG VEIN DRAINAGE ANOMALY; MOLECULAR DYNAMICS; NOONAN SYNDROME; PALLISTER KILLIAN SYNDROME; PATAU SYNDROME; PATENT DUCTUS ARTERIOSUS; PHENOTYPE; PREVALENCE; PULMONARY VALVE STENOSIS; REVIEW; SYNDROME; TURNER SYNDROME; WOLF HIRSCHHORN SYNDROME;

EID: 33645552610     PISSN: 09716866     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-6866.16289     Document Type: Review

References (72)

1. Srivastava D. Genetic assembly of the heart: Implication of congenital heart disease. Annu Rev Physiol 2001;63:451-69.
2. Epstein JA, Buck CA. Transcriptional Regulation of cardiac development implications for CHD and Digeorge syndrome. Pediatr Res 2000;48:717-24.
3. Bruneau BG. Transcriptional regulation of vertebrate cardiac morphogenesis. Circ Res 2002;90:509-19.
4. http://www.americanheartassociation.com/Heart disease and stroke statistics-2003 update
5. Frias JL. Genetic issues of congenital heart disease. In: Gessner IH, Victrorica BE, editors. Pediatric cardiology. Philadelphia: Saunders; 1993. p. 237-42.
6. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900.
7. Chadha SL, Singh N, Shukla DK. Epidemiological study of congenital heart disease. Indian J Pediatr 2001;68:507-10.
8. Thakur JS, Negi PC, Ahluwalia SK, Sharma R, Bhardwaj R. Congenital heart disease among school children in Shimla hills. Indian Heart J 1995;47:232-5.
9. th.
10. http://www.americanheartassociation.com/The Merck Manual of Diagnosis.
11. Zaret BL. Diagnosis: Steps In Making A Diagnosis, Chapter 10. p. 115-28.
12. Payne M, Johnson MC, Grant JW, Strauss AW. Towards a molecular understanding of congenital heart disease. Circulation 1995;91:494-504.
13. http://www.noah.cuny.edu/pregnancy/march_of_dimes/birth_disease/congnitl. html
14. Burn J, Goodship J. Development genetics of the heart. Curr Opin Genet Dev 1996;6:322-5.
15. Chaoui R, Korner H, Bommer C, Goldner B, Bierlich A, Bollmann R. Prenatal diagnosis of heart disease and associated chromosomal aberrations. Ultraschall Med 1999;20:177-84.
16. Hook EB, Fabia JJ. Frequency of Down syndrome in live births by single year maternal age interval; results of a Massachusetts study. Teratology 1978;17:223-8.
17. Root S, Carey JC. Survival in trisomy 18. Am J Med Genet 1994;49:170-4.
18. Musewe NN, Alexander DJ, Teshima I, Smallhorn JF, Freedom RM. Echocardiographic evaluation of the spectrum of cardiac anomalies associated with trisomy 13 and trisomy 18. J Am Coll Cardiol 1990;15:673-7.
19. Chu CE, Donaldson MD, Kelnar CJ, Smail PJ, Greene SA, Paterson WF, et al. Possible role of imprinting in the Turner phenotype. J Med Genet 1994;31:840-2.
20. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turners syndrome. Italian study group for Turner syndrome (ISGTS). J Pediatr 1998;133:688-92.
21. Paul T, Reimer A, Wilken M, Miller K, Kallfelz HC. Complex cyanotic heart disease in a new born infant with cat eye syndrome. Monatsschr Kinderheilkd 1991;139:228-30.
22. Reylonds JF, Daniel A, Kelly TE, Gollin SM, Stephan MJ, Carey J, et al. Isochromosome 12pmosaicism (Pallister mosaic aneuploidy or Pallister-Killian syndrome): Report of 11 cases. Am J Med Genet 1987;27:257-74.
23. Hagerman R. Fragile X syndrome In: Cassidy SB, Allanson JE, editors. Management of Genetic Syndrome. New York: Wiley-Liss; 2001;554:165-83.
24. Prasad C, Chudley AE. Genetics and Cardiac Anomalies: the Heart of the Matter. Indian J Pediatr 2002;69:321-32.
25. Chung MY, Lu JH, Weng YY, Hwang B. Absences of mutations in human Ubiquituin fusion-degradation protein gene in Teratology of Fallot. J Mol Med 2001;79:338-42.
26. Kim MS, Basson CT. Wrapping up DiGeorge Syndrome in a T-box?. Nature Genet 2001;27:286-91.
27. Driscoll DA, Budarf MI, Emanuel BS. A genetic etiology of Digeorge syndrome. Genomics 1991;10:201-6.
28. Wilson DI, Cross IE, Goodship JA, Brown J, Scambler PJ, Bain HH, et al. A prospective Cytogenetic study of 36 cases of Digeorge syndrome. Am J Hum Genet 1992;51:957-63.
29. Goldmutz E, Geiger E, Benson W. NKX2.5 mutations in patients with TOF. Circulation 2001;104:2565-8.
30. Johnson VP, Mulder RD, Hosen R. The Wolf-Hirschhorn (4p) syndrome. Clin Genet 1976;10:104-12.
31. Battaglia A, Carey JC, Cederholm P, Viskochil DH, Brothman AR, Galasso C. Natural history of Wolf-Hirschhorn syndrome: Experience with 1 case. Pediatrics 1999;103:830-6.
32. Christiansen J, Dyck JD, Elyas BG, Lilley M, Bamforth JS, Hicks M, et al. Chromosome 1q21.1 Contiguous Gene Deletion is Associated with Congenital heart disease. Circ Res 2004. p. 1 -7.
33. Burch M, Sharland M, Shinebourne E, Smith G, Pattern M, McKenna W. Cardiologic abnormalities in Noonan syndrome phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol 1993;22:1189-92.
34. Marino B, Digilio MC, Novelli G, Giannotti A, Dallapiccola B. Tricuspid Artesia and 22 q11 deletion. Am J Med Genet 1997;72:40-2.
35. Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B. Congenital heart disease in Kabuki syndrome. Am J Med Genet 2001;100:269-74.
36. Mc Kusick VA. Ellis-Van Creveld syndrome and the Amish. Nat Genet 2000;24:203-4.
37. Ruiz-Perez VL, Ide SE, Strom TM, Lorenz B, Wilson D, Woods K, et al. Mutations in a new gene in Ellis-Van creveld syndrome and weyers acrodental dysostosis. Nat Genet 2000;21:283-6.
38. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach MG, Moak JP, et al. Congenital heart disease caused by mutations in the transcription factor NKX2.5. Science 1998;281:108-11.
39. Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, Zhang Y, Riggs S, et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac development pathways. J Clin Invest 1999;104:1567-73.
40. McElhinney DB, Geiger E, Blinder J, Benson W, Goldman E. NKX2.5 Mutations in patients with congenital heart disease. American J Cardiol 2003;42:1650-5.
41. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, et al. GATA4 mutations cause human congenital heart disease and reveal an interaction with TBX5. Nature 2003;424:443-7.
42. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, et al. Mutation in human TBX5 cause limb and cardiac malformation in Holt Oram syndrome. Nat Gent 1997;15:30-5.
43. Yang J, Hu D, Xia J, Yang Y, Ying B, Hu J, et al. Three novel TBX5 mutations in Chinese patients with Holt Oram syndrome. Am J Med Genet 2000;92:237-40.
44. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH, et al. Holt Oram syndrome is caused by mutations in TBX5 a member of the Brachyury (T) gene family. Nat Genet 1997;15:21-9.
45. Srivastava D. HAND proteins: Molecular mediators of cardiac development and congenital heart disease. Trends Cardiovasc Med 1999;9:11-8.
46. Natarajan A, Yamagishi H, Ahmad F, Li D, Roberts R, Matsuoka R, et al. Human eHAND, but not dHAND is down regulated in cardiomyopathesies. J Mol Cell Cardiol 2001;33:1607-14.
47. Bruneau BG, Bao ZZ, Tanaka M, Schott JJ, Izumo S, Cepko CL, et al. Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Dev Biol 2000;217:266-77.
48. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, et al. Alagille syndrome is caused by Mutations in human Jagged 1, which encodes a Ligand for Notch 1. Nat Genet 1997;16:243-51.
49. Zalzstein E, Moes CA, Musewe NN, Freedom RM. Spectrum of cardiovascular anomalies in Williams Beuren syndrome. Pediatr cardiol 1991;12:219-23.
50. Sacoda M, et al. Mutations in TFAP2B cause char syndrome a familial form of patent ductus arteriosus. Nature Genet 2000;25:42-6.
51. Francke U, Furthmayr H. Genes and gene products involved in Marfan syndrome. Semin Thorac Cardiovasc Surg 1993;5:3-10.
52. Srivastava D, Olson EN. A genetic blue print for cardiac development. Nature 2000;407:221-6.
53. Bound JP, Logan WF. Incidence of congenital heat disease in Blackpool 1957-1971. Br Heart J 1977;39:445-50.
54. Kenna AP, Smithells RW, Fielding DW. Congenital heart disease in Liver pool: 1960-69. Q J Med 1975;44:17-44.
55. Samanek M, Slavik Z, Krejcir M. Seasonal differences in the incidence of congenital heart disease. Czech Med 1991;14:146-55.
56. Bitar FF, Baltaji N, Dbaibo G, Abed el-Jawad M, Yunis KA, Obeid M. Congenital heart disease at a tertiary care centre in Lebanon. J Anesthesiol 1999;15:151-64.
57. Samanek M, Slavik Z, Krejcir M. Congenital heart disease among 815,569 children born 1980 and 1990 and their 15 year survival: A prospective Bohemia survival study. Pediatr Cardiol 1999;20:411-7.
58. Bower C, Ramsay JM. Congenital heart disease: A 10 year cohort. J Paediatr Child Health 1994;30:414-8.
59. Kidd SA, Lancaster PAL, McCredie RM. The incidence of congenital heart disease in the first year of life. J Paediatr Child Health 1993;29:344-9.
60. Robida A, Folger GM, Hajar HA. Incidences of congenital heart disease in Qatari children. Int J Cardiol 1997;60:19-22.
61. Meberg A, Otterstad JE, Froland G, Sorland S, NitterHauge S. Increasing incidence of ventricular septal disease caused by improved detection rate. Acta Paediatr 1994;83:653-7.
62. Hassan I, Haleem AA, Bhutta ZA. Profile and risk factors for congenital heart disease. J Pak Med Assoc 1997;47:78-81.
63. Bolisetty S, Daftary A, Ewald D, Knight B, Wheaton G. Congenital heart disease in Central Australia. Med J Aust 2004;180:614-7.
64. 1998 Annual report of the South Australian Birth Disease Register. Adelaide: Women's and Children's Hospital; 2000. p. 7.
65. Subramanyan R, Joy J, Venugopalan P, Sapru A, al Khusaiby SM. Incidence and spectrum of congenital heart disease in Oman. Ann Trop Paediatr 2000;20:337-41.
66. Begic H, Tahirovic H, Mesihovic-Dinarevic S, Ferkovic V, Atic n, Latifagic A. Epidemiological and clinical aspects of congenital heart disease in children in Tuzla Canton, Bosnia-Herzegovina. Eur J Pediatr 2003;162:191-3.
67. Bassili A, Mokhtar SA, Dabous NI, Zaher SR, Mokhtar MM, Zaki A. Congenital heart disease among school children in Alexandria, Egypt: An overview on prevalence and relative frequencies. J Trop Pediatr 2000;46:357-62.
68. Alabdulgader A. Congenital heart disease in 740 subjects: Epidemiological aspects. Ann Trop Paediatr 2001;21:111-8.
69. Venugopalan P, Agarwal AK. Spectrum of congenital heart disease associated with Downs in high consanguineous Omani population. Int J Cardiol 2002;4:211-6.
70. Wickramasinghe P, Lambadusuriya SP, Narenthiran S. Prospective study of congenital heart disease in children. Ceylon Med J 2001;46:96-8.
71. Suresh V, Rao AS, Yavagal ST. Frequency of various congenital heart disease: analysis of 3790 consecutively catheterized patients. Indian heart J 1995;7:125-8.
72. Hosoda T, Komuro I, Shiojima I, Hiroi Y, Harada M, Murakawa Y, et al. Familial atrial septal disease and atrioventricular conduction disturbance associated with a point mutations in the cardiac homeobox gene CSX/NKX2.5 in a Japanese patient. Jpn Circ J 1999;63:425-6.